Eller Mark G. 4
4 · JAZZ PHARMACEUTICALS INC · Filed Jun 2, 2011
Insider Transaction Report
Form 4
Eller Mark G.
SVP, Research & Clinical Dev.
Transactions
- Other
Common Stock
2011-05-31$0.85/sh+3,461$2,942→ 3,461 total
Footnotes (1)
- [F1]Shares acquired through a qualified Section 423 Employee Stock Purchase Plan.